Achieve Life Sciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ACHV | IAM | CADL | VIVOBIOT.BO | ZVRA | ATAI | |
|---|---|---|---|---|---|---|
| Market cap | 719.66M | 635.17M | 692.49M | 328.87M | 663.32M | — |
| P/E (TTM) | — | — | — | — | 9.2 | — |
| Forward P/E | -10.7 | — | -14.5 | — | 10.4 | — |
| Price/book | -48.8 | -1.4 | 5.5 | 0.3 | 2.8 | — |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +47.26% | −29.14% | +83.20% | −57.71% | +22.88% | — |
| Today | +3.71% | −0.67% | +2.61% | +6.77% | +8.87% | 0.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ACHV news ›Achieve Life Sciences (NASDAQ:ACHV) Stock Falls 6.8% – Time to Sell?
Posted by Sarita Garza on Nov 4th, 2026 Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Free Report)’s stock price traded down 6.8% during trading on Monday. The company traded as low as $6.44 and last traded at $6.3650. 475,831 shares…
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
markets.businessinsider.com Achieve Life Sciences Announces Granting of New Hire Inducement Awards SEATTLE and VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-sta
More from 1 other outlet
Achieve Life Sciences presents positive 52-week cytisinicline results
Achieve Life Sciences (ACHV) announced positive 52-week efficacy results from its long-term, open-label ORCA-OL clinical trial evaluating cytisi... Achieve Life Sciences presents positive 52-week cytisinicline results Achieve Life Sciences…
Roth Capital Initiates Annovis Bio at Buy With $8 Price Target
... Biotechnology & Medical Research Roth Capital Initiates Annovis Bio at Buy With $8 Price Target Published on 07/08/2026 at 08:08 am EDT
Kepler Cheuvreux resumes coverage of Afry with reduce and a price target of 100 kronor
Kepler Cheuvreux resumes coverage of Afry with reduce and a price target of 100 kronor Published on 08/12/2026 at 03:42 am EDT Latest news about Afry AB Income Statement and Estimates This super rating is the
Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (ACHV), AngioDynamics (ANGO)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Achieve Life Sciences (ACHV), AngioDynamics (ANGO) and Helus Pharma (HELP) with bullish sentiments. Achieve Life Sciences (ACHV) In a report…
Stifel Nicolaus Initiates Coverage on Candel Therapeutics With Buy Rating, $22 Price Target
... Biotechnology & Medical Research Stifel Nicolaus Initiates Coverage on Candel Therapeutics With Buy Rating, $22 Price Target Published on 07/13/2026 at 07:28 am EDT
Award Acceptance and Activation
Award acceptance includes verification of award information, reviewing, negotiating and accepting terms and conditions, activating sponsored project PTA (Project Task Award). Receipt, Intake & Review
American Clean Resources appoints Anthony Evers CFO
Lianhe Sowell International Group Ltd. Secures RMB23.84 Million Order for 80 AI Spray Painting Robots in Malaysia and First UK Order Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical…
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Stock Has Average Target Price of $15.50
Posted by Defense World Staff on Oct 19th, 2026 View Our Latest Stock Report on Achieve Life Sciences Achieve Life Sciences (NASDAQ:ACHV – Get Free Report) last posted its earnings results on Tuesday, August 11th. The biopharmaceutical…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com14
- markets.businessinsider.com10
- stocktitan.net7
- tradingview.com3
- marketbeat.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 47 articles, not a forecast.